Chromatography devices and methods of use
The chromatography device with AEX and HIC layers simplifies nucleic acid purification by reducing buffer consumption and maintaining biomolecule stability, addressing inefficiencies in existing methods.
Patent Information
- Application Number
- JP2023064859
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2022-04-15
- Filing Date
- 2023-04-12
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2043-04-12
AI Technical Summary
Existing chromatography devices and methods for RNA and DNA purification are inefficient and require complex processes with high buffer consumption, particularly when dealing with high salt concentrations.
A chromatography device comprising a filter housing with a porous filter containing a first anion exchange (AEX) layer and a second hydrophobic interaction (HIC) layer, allowing for a single operation to purify nucleic acids with reduced buffer consumption and high flow rates.
The device enables high-purity nucleic acid purification with reduced complexity and buffer use, maintaining stability of biomolecules like lentiviruses and adenoc-associated viruses (AAVs) by using low conductivity buffers.
Smart Images

Figure 0007577153000001 
Figure 0007577153000002 
Figure 0007577153000003
Abstract
Description
[Technical field]
[0001] [Background of the invention]
[0001] RNA (eg, lentiviral RNA) and DNA (eg, plasmid DNA) purification generally requires the use of different chromatography devices and the dilution of high salt concentrations into low conductivity buffers.
[0002]
[0002] There is a need for improved chromatography devices and methods of purification.
[0003]
[0003] The present invention provides an improvement over at least some of the shortcomings of the prior art. These and other advantages of the present invention will become apparent from the following description.
[0004] [Brief Summary of the Invention]
[0004] One aspect of the present invention provides a chromatography device comprising: (a) a filter housing having an inlet and an outlet and defining a fluid flow path between the inlet and the outlet; and (b) a porous filter disposed in the filter housing across the fluid flow path, the porous filter comprising: (i) a first porous filter element; and (ii) a second porous filter element in contact with the first porous filter element, the second porous filter element being disposed downstream of the first porous filter element, the first porous filter element comprising at least one anion exchange (AEX) layer and the second porous filter element comprising at least one hydrophobic interaction (HIC) layer.
[0005]
[0005] Another aspect of the invention is a method for purifying nucleic acid comprising: (a) a filter housing having an inlet and an outlet, the filter housing defining a fluid flow path between the inlet and the outlet; and (b) a porous filter disposed in the filter housing across the fluid flow path, the porous filter including: (i) a first porous filter element; and (ii) a second porous filter element in contact with the first porous filter element, the second porous filter element being disposed downstream of the first porous filter element; The method includes the steps of: passing a fluid containing nucleic acid through a chromatography device, wherein a first porous filter element includes at least one anion exchange (AEX) layer and a second porous filter element includes at least one hydrophobic interaction (HIC) layer; binding the nucleic acid to the at least one AEX layer; eluting the nucleic acid from the at least one AEX layer into a high salt solution; binding the nucleic acid to the at least one HIC layer; and eluting the nucleic acid into a low salt buffer. [Brief description of the drawings]
[0006] [Figure 1A] 1A and 1B are diagrams showing an embodiment of a chromatography device having a planar filter configuration according to one embodiment of the present invention, in which Figures 1A and 1B show top and bottom perspective views, respectively, of an assembled chromatography device having a housing and an annular outlet portion engaged with the housing. [Figure 1B] 1A and 1B are diagrams showing an embodiment of a chromatography device having a planar filter configuration according to one embodiment of the present invention, in which Figures 1A and 1B show top and bottom perspective views, respectively, of an assembled chromatography device having a housing and an annular outlet portion engaged with the housing. [Figure 1C] 1A-1C are diagrams showing an embodiment of a chromatography device having a planar filter configuration according to one embodiment of the present invention. FIG 1C shows a cross-sectional view of the assembled device shown in FIG 1A, also showing the annular inlet plate and filter. [Figure 1D]1A-1H are drawings showing an embodiment of a chromatography device having a planar filter configuration according to one embodiment of the present invention, in which FIG. 1D shows an exploded view of the device, and FIG. 1F, FIG. 1G, and FIG. 1H show top, bottom, and partial cut-away views, respectively, of the annular inlet plate. [Figure 1E] 1A-1H are drawings showing an embodiment of a chromatography device having a planar filter configuration according to one embodiment of the present invention, in which FIG. 1D shows an exploded view of the device, and FIG. 1F, FIG. 1G, and FIG. 1H show top, bottom, and partial cut-away views, respectively, of the annular inlet plate. [Figure 1F] 1A-1H are drawings showing an embodiment of a chromatography device having a planar filter configuration according to one embodiment of the present invention, in which FIG. 1D shows an exploded view of the device, and FIG. 1F, FIG. 1G, and FIG. 1H show top, bottom, and partial cut-away views, respectively, of the annular inlet plate. [Figure 1G] 1A-1H are drawings showing an embodiment of a chromatography device having a planar filter configuration according to one embodiment of the present invention, in which FIG. 1D shows an exploded view of the device, and FIG. 1F, FIG. 1G, and FIG. 1H show top, bottom, and partial cut-away views, respectively, of the annular inlet plate. [Figure 1H] 1A-1H are drawings showing an embodiment of a chromatography device having a planar filter configuration according to one embodiment of the present invention, in which FIG. 1D shows an exploded view of the device, and FIG. 1F, FIG. 1G, and FIG. 1H show top, bottom, and partial cut-away views, respectively, of the annular inlet plate. [Figure 1I] 1A-1K are drawings showing an embodiment of a chromatography device having a planar filter configuration according to one embodiment of the present invention, respectively showing a top perspective view, a bottom perspective view, and a partial cutaway view of the annular outlet shown in FIG. [Figure 1J] 1A-1K are drawings showing an embodiment of a chromatography device having a planar filter configuration according to one embodiment of the present invention, respectively showing a top perspective view, a bottom perspective view, and a partial cutaway view of the annular outlet shown in FIG. [Figure 1K]1A-1K are drawings showing an embodiment of a chromatography device having a planar filter configuration according to one embodiment of the present invention, respectively showing a top perspective view, a bottom perspective view, and a partial cutaway view of the annular outlet shown in FIG. [Figure 2A] 2A-2C are diagrams of a chromatography device according to another embodiment of the present invention having a cylindrical hollow filter configuration. [Figure 2B] 2A and 2B are drawings of a chromatography device according to another embodiment of the invention having a cylindrical hollow filter configuration. [Figure 2C] 2A and 2B are drawings of a chromatography device according to another embodiment of the invention having a cylindrical hollow filter configuration. [Figure 2D] 2A-2D are diagrams of a chromatography device according to another embodiment of the invention having a cylindrical hollow filter configuration. [Figure 2E] 2A-2H are drawings of a chromatography device according to another embodiment of the invention having a cylindrical hollow filter configuration, with Figures 2E and 2F showing bottom perspective and cross-sectional views, respectively, of the inlet portion of the device, and Figures 2G and 2H showing side and cross-sectional views, respectively, of the outlet portion of the device. [Figure 2F] 2A-2H are drawings of a chromatography device according to another embodiment of the invention having a cylindrical hollow filter configuration, with Figures 2E and 2F showing bottom perspective and cross-sectional views, respectively, of the inlet portion of the device, and Figures 2G and 2H showing side and cross-sectional views, respectively, of the outlet portion of the device. [Figure 2G] 2A-2H are drawings of a chromatography device according to another embodiment of the invention having a cylindrical hollow filter configuration, with Figures 2E and 2F showing bottom perspective and cross-sectional views, respectively, of the inlet portion of the device, and Figures 2G and 2H showing side and cross-sectional views, respectively, of the outlet portion of the device. [Figure 2H]2A-2H are drawings of a chromatography device according to another embodiment of the invention having a cylindrical hollow filter configuration, with Figures 2E and 2F showing bottom perspective and cross-sectional views, respectively, of the inlet portion of the device, and Figures 2G and 2H showing side and cross-sectional views, respectively, of the outlet portion of the device. [Figure 2I] 2A-2I are drawings of a chromatography device according to another embodiment of the invention having a cylindrical hollow filter configuration. [Diagram 3] FIG. 2 shows a perspective view of a chromatography device according to another embodiment of the present invention.
[0007] [Detailed Description of the Invention]
[0009] According to one aspect of the present invention, there is provided a chromatography device comprising: (a) a filter housing having an inlet and an outlet, the filter housing defining a fluid flow path between the inlet and the outlet; and (b) a porous filter disposed in the filter housing across the fluid flow path, the porous filter comprising: (i) a first porous filter element; and (ii) a second porous filter element in contact with the first porous filter element, the second porous filter element being disposed downstream of the first porous filter element, the first porous filter element comprising at least one anion exchange (AEX) layer and the second porous filter element comprising at least one hydrophobic interaction (HIC) layer.
[0008]
[0010] In one embodiment of the chromatography device, the AEX layer(s) and the HIC layer(s) are planar membranes.
[0009]
[0011] In another embodiment of the chromatography device, the AEX layer(s) and the HIC layer(s) are arranged to form a hollow cylindrical filter, e.g., to allow radial flow, with the AEX layer surrounding the HIC layer.
[0010]
[0012] A typical embodiment of a chromatography device includes at least two AEX layers and at least two HIC layers.
[0011]
[0013] In another aspect, a method for purifying nucleic acids is provided comprising: (a) a chromatography device comprising a filter housing having an inlet and an outlet, the filter housing defining a fluid flow path between the inlet and the outlet; and a porous filter disposed in the filter housing across the fluid flow path, the porous filter comprising: a first porous filter element; and a second porous filter element in contact with the first porous filter element, the second porous filter element being disposed downstream of the first porous filter element, the first porous filter element comprising at least one The method includes the steps of: (a) passing a fluid containing nucleic acids through a chromatography device comprising an anion exchange (AEX) layer of at least one nucleic acid and a second porous filter element comprising at least one hydrophobic interaction (HIC) layer; (b) binding the nucleic acids to the at least one AEX layer; (c) eluting the nucleic acids from the at least one AEX layer into a high salt buffer; (d) binding the nucleic acids to the at least one HIC layer; and (e) eluting the nucleic acids from the at least one HIC layer into a low salt buffer.
[0012]
[0014] Advantageously, a single chromatography device can be used, and the method for purification is less complicated than conventional methods, reducing buffer consumption. For example, two purification acts are carried out in one operation at high flow rate (10 membrane volumes / min). Lentivirus and AAV can be eluted from the hydrophobic interaction medium with a low conductivity buffer that favors their stability.
[0013]
[0015] Each of the components of the present invention will now be described in more detail below, with like components having like reference numerals.
[0014]
[0016] Figures 1A-1K are drawings showing one embodiment of a chromatography device having a planar filter configuration according to one embodiment of the present invention: Figures 1A and 1B show top and bottom perspective views, respectively, of an assembled device with a housing and an annular outlet portion engaged with the housing; Figure 1C shows a cross-sectional view of the assembled device shown in Figure 1A, also showing an annular inlet plate and a filter; Figure 1D shows an exploded view of the device, and Figures 1F, 1G, and 1H show top, bottom, and partial cut-away views, respectively, of the annular inlet plate; Figures 1I, 1J, and 1K show top, bottom, and partial cut-away views, respectively, of the annular outlet portion shown in Figure 1B.
[0015]
[0017] 1A-1K show a filter housing 10 having a bottom surface 1004 including an annular inner diameter D bounded by a threaded inner wall 10' (for threadable engagement with a threaded outer wall 12' of annular outlet portion 12), a sidewall that also includes an inwardly facing portion 1025 having a smaller inner diameter d1 near the bottom surface 1004, an annular protruding ring 1015, and an annular shoulder 1020 surrounding the base of an opening 1010 (for receiving a protrusion of an annular inlet plate); an annular inlet plate 11 having a protruding portion 1101 including an optional inlet 11A, an upper surface 1103, a lower surface 1104 including an annular protruding ring 1115 providing an inlet chamber 11B (shown in a generally concave configuration so as to widen towards the filter); and an annular outlet portion 12A having an annular outer diameter D2 surrounded by a threaded outer wall 12', the outlet portion having an inner surface including a groove 75A containing a resilient element 71 such as an o-ring and an inner groove 75B. 1204, an annular protruding ring 1215 providing an outlet chamber 12B (shown with a generally concave configuration so as to widen towards the filter), and an outlet 12A with internal threads 1202, the device defining a fluid flow path 13 between an inlet and an outlet, the filter including a porous filter 150 (shown with a planar configuration) disposed in the filter housing across the fluid flow path, the filter including a first porous filter element 151 (which may have at least two layers) and a second porous filter element 152 (which may have at least two layers) in contact with the first porous filter element, the first porous filter element including at least one anion exchange (AEX) layer, the second porous filter element including at least one hydrophobic interaction (HIC) layer, and the first porous filter element 151 disposed upstream of the second porous filter element 152. Preferably, an optional support element 160, such as a mesh or screen, is disposed downstream of the porous filter element, e.g., the support element 160 contacts a downstream surface of the second porous filter element 152. Alternatively or in addition, the support element, or a separate support element, may be disposed upstream of the porous filter element, e.g., the support element contacts an upstream surface of the first porous filter element 151.
[0016]
[0018] Although this illustrated embodiment shows threaded inlets and outlets (e.g., for connecting with conduits having threaded ends or fittings), embodiments of the invention are not so limited and other connections (e.g., tri-clamp / sanitary flange connections) are within the skill of one in the art (see also Figures 2A-2H and 3, which show inlets and outlets each having a connecting surface with an annular groove for receiving a resilient member such as an o-ring).
[0017]
[0019] 2A-2I show an inlet portion 21A having an inlet chamber 21B with an annular inner diameter D3 surrounded by a threaded inner wall 20' (for threadable engagement with the threaded outer wall 22' of the outlet portion 22), the sidewall also including an inwardly facing portion 2025 with a smaller inner diameter d3 near the bottom surface 2004; and a lower end 25 with a bottom surface 25' (which will contact the upper surface of the inlet portion's inwardly facing portion 2025 when the inlet and outlet portions are fully engaged), a threaded inner wall 20' (for threadable engagement with the inlet portion's threaded inner wall 20'). 2A shows another embodiment of a chromatography device 200 (FIG. 2A shows a perspective view, and FIGS. 2B and 2C show different cross-sectional views of the assembled device) comprising a filter housing 20 having an annular outer diameter D3 surrounded by a threaded outer wall 22' and an annular inner diameter D4 surrounded by an inner wall 24', a filter chamber 22B having a top wall 26', and an outlet section 22 having an outlet 22A providing a filter cartridge outlet chamber 28B (upstream / downstream of the filter chamber 22B) for receiving an outlet 273 of a filter cartridge 270. In this illustrated embodiment (see FIGS. 2G and 2H), the unthreaded portion of the side wall 22' near the bottom end 25 includes a groove 27 for receiving a resilient element such as an o-ring (e.g., to improve the fluid tight seal between the inlet and outlet sections); FIG. 2I shows a partial cutaway view of the top of the device.
[0018]
[0020] The device 200 defines a fluid flow path 23 (see FIG. 2B) between an inlet and an outlet with a filter cartridge 270 including a hollow cylindrical porous filter 250 (see FIG. 2I), the filter cartridge and filter being disposed in a filter housing across the fluid flow path, the hollow cylindrical porous filter including a first porous filter element 251 and a second porous filter element 252 in contact with the first porous filter element, the first porous filter element including at least one anion exchange (AEX) layer, the second porous filter element including at least one hydrophobic interaction (HIC) layer, and the first porous filter element 251 being disposed upstream of and surrounding the second porous filter element 252 (each porous filter having a hollow cylindrical configuration; FIG. 2I shows a filter 250 including laid-over pleated filter elements 251 and 252). The illustrated filter cartridge has a closed bottom end cap 271 [having a bottom surface 271A and a top surface 271B with grooves 272 (to direct flow outward)] and an open top end cap 272 (having an outer wall with at least one groove shown as two grooves 274A, 274B for receiving a resilient element such as an o-ring) containing a hollow elongated cartridge outlet 273, and an optional support element such as an inner core 260 having a first end 260A and a second end 260B (ends with respective open chambers 262A, 262B with a solid portion 263 therebetween) and a sidewall near the second end 260B with perforations 264 passing through the sidewall to the open chambers (the illustrated inner core has ribs 266 and grooves 267 shown disposed at a continuous angle from the first end to the second end on the outer surface of the sidewall, which may improve the flow of liquid toward the outlet), and an outer mesh or cage 261.
[0019]
[0021] In some embodiments, the first porous filter element 251 is a pleated element and can be a laid-over pleated element. In some embodiments, the second porous filter element 252 is a pleated element and can be a laid-over pleated element. For example, the first and second porous elements can both be pleated elements (e.g., as shown in FIG. 2I). Alternatively, the second porous element can wrap around the first porous element.
[0020]
[0022] Preferably, device 200 includes vents, with inlet section 21 including a threaded vent port 290 and a threaded vent valve 291 and outlet section 22 including a threaded vent port 292 and a threaded vent valve 293.
[0021]
[0023] In embodiments where the device includes a vent, the device should be operated with the vent(s) open and flowing upwards to efficiently displace air from the device. Thus, the inlet side of the device should be facing down to establish a uniform fluid flow through the filter so that air can be displaced from the device. Failure to follow this procedure can result in increased pressure and poor chromatographic performance, so it may be desirable to connect a pressure gauge upstream of the device inlet to monitor the pressure. The vent(s) should be opened when liquid flow is first established and closed when all of the air has been displaced by liquid. The inlet side of the device should then be facing up to allow liquid to pass through the device.
[0022]
[0024] 3 is a diagram showing a perspective view of another embodiment of a chromatography device 300 according to the present invention, comprising a filter housing 320 having an inlet portion 321 with an inlet 321A and an outlet portion 322 (threadably engagable with the inlet portion), with threaded vent valves 391 and 393. Except for the lengths of the inlet portion 321 and the outlet portion 322 [and the corresponding lengths of the internal elements (such as elements including a filter cartridge, an inlet chamber, a filter chamber and a filter cartridge outlet chamber, etc.)] and the diameters of the connections of the inlet 321A and the outlet 322A (which are larger in device 300), the structure and operation of device 300 essentially corresponds to that of device 200.
[0023] Anion Exchange Layer
[0025] In general, an anion exchange (AEX) layer is any semipermeable membrane that contains a substrate that contains fixed positively charged (cationic) functional groups and a mobile anion (counterion) that allows the selective permeation of negatively charged (anionic) species. The substrate is any suitable material, preferably a hydrophilic material such as polyethersulfone (PES), cellulose, methacrylate, hydrophilic polymers, or any combination thereof.
[0024]
[0026] In some embodiments, the substrate in the AEX layer comprises a polyethersulfone substrate that is hydrophilic and may or may not include a crosslinked coating. In a preferred embodiment of the invention, the polyethersulfone substrate has a crosslinked coating that includes pendant cationic groups, particularly quaternary ammonium groups.
[0025]
[0027] The crosslinked coating generally comprises a polyamine, a diallylamine copolymer (e.g., a diallylamine copolymer with epoxy groups) and / or an acrylic copolymer, one or more of which contain pendant cationic groups attached directly or indirectly to the polymer backbone. Optionally, the diallylamine copolymer can be reacted with epichlorohydrin to provide epoxy sites. The polyamine can be, for example, diethylenetriamine, triethylenetetramine, tetraethylenepentamine, pentaethylenehexamine or polyethyleneimine.
[0026]
[0028] For example, the crosslinked coating can include the reaction product of a polyamine (e.g., polyethyleneimine) with pendant cationic groups (e.g., quaternary ammonium groups), and optionally a polyalkylene glycol polyglycidyl ether. In another example, the crosslinked coating is prepared by crosslinking a composition that includes diallylamine, diallyldialkylammonium halide, an acrylic monomer with a cationic group (e.g., quaternary ammonium group), and a crosslinker. In another example, the crosslinked coating is prepared by crosslinking a composition that includes a diallylamine copolymer with epoxy groups and pendant cationic groups, polyethyleneimine, and an amine-reactive compound with a cationic group (e.g., glycidyltrimethylammonium chloride). In another example, the crosslinked coating includes a diallylamine copolymer, an acrylic monomer with a quaternary ammonium group, and a crosslinker [e.g., N-(alkoxymethyl)acrylamide]. In another example, the crosslinked coating comprises a diallylamine copolymer, an acrylic monomer having a quaternary ammonium group (e.g., an acryloylaminoalkyltrialkylammonium halide or an acryloyloxyalkyltrialkylammonium halide), and a crosslinker. In another example, the crosslinked coating comprises an acrylic copolymer having pendant cationic groups and comprising polymerized monomers selected from the group consisting of glycidyl alkyl acrylates, methacryloyloxyalkyltrialkylammonium halides, and methacryloylaminoalkyltrialkylammonium halides. In another example, the crosslinked coating comprises an acrylic copolymer having pendant cationic groups and linked to pentaethylenehexamine.
[0027]
[0029] The coating may be crosslinked using any suitable method and / or crosslinking agent. Crosslinking agents are polyfunctional agents, such as urea, halo, epoxy, isocyanate, carboxyl, or acid chloride, that have functional groups that are reactive with groups (e.g., amino) in the backbone of one or more of the polymers in the coating. A preferred crosslinking agent is a polyglycidyl compound. An example of a suitable polyglycidyl compound is polyalkylene glycol polyglycidyl ether. Examples of crosslinking agents include ethylene glycol diglycidyl ether, 1,4-butanediol diglycidyl ether, N-(isobutoxymethyl)acrylamide, N-(isobutoxymethyl)methacrylamide, epichlorohydrin, epibromohydrin, and combinations thereof. Crosslinking may occur in a solvent that includes water, at least one organic solvent, or a mixture thereof. Optionally, a catalyst, such as a strong base (e.g., sodium hydroxide, potassium hydroxide), may be used.
[0028]
[0030] In a preferred embodiment, the coating solution comprises diallylamine, diallyldialkylammonium halide, a copolymer of acrylic monomers having cationic groups (eg, quaternary ammonium groups), and a crosslinker.
[0029]
[0031] The coating composition can be prepared, for example, by dissolving the monomer (e.g., polyamine) in a suitable solvent (e.g., water, alcohols such as methanol, ethanol, and propanol, and combinations thereof). The solvent can be present in an amount of about 40% to about 99%, preferably about 90% to about 99%, by weight of the coating composition. The monomer can be present in an amount of about 1% to about 5%, preferably about 1% to about 2.5%, by weight of the coating composition. Once the coating solution is applied to the substrate using any suitable technique (e.g., dip coating, spray coating, etc.), the solution can be cured to form a crosslinked coating on the substrate such that an AEX layer is formed.
[0030]
[0032] PES substrates containing crosslinked coatings are further described, for example, in US Pat. No. 6,780,327.
[0031]
[0033] In some embodiments, the substrate in the AEX layer comprises cellulose. Suitable cellulose polymers include cellulose, regenerated cellulose, cellulose esters (e.g., cellulose acetate, cellulose propionate, cellulose butyrate, cellulose acetate butyrate), cellulose nitrate (also known as nitrocellulose), methylcellulose, ethylcellulose, and combinations thereof (e.g., a mixture of cellulose acetate and cellulose nitrate).
[0032]
[0034] In some embodiments, the substrate in the AEX layer comprises a methacrylate polymer. Examples of methacrylate polymers include polymethyl methacrylate and methyl methacrylate copolymers.
[0033]
[0035] In some embodiments, the substrate in the AEX layer comprises a hydrophilic polymer. Examples of suitable hydrophilic polymers include polyamides, polyimides, polyalkylene oxides, hydrophilic polyurethanes, polyvinylpyrrolidones, polyacrylamides, polyacrylic acids, and polyvinyl alcohols. Examples of polyamides include nylons, such as nylon 4,6, nylon 6, nylon 6,6, nylon 11, and / or nylon 12. Examples of polyimides include aliphatic polyimides, aromatic polyimides, or mixtures thereof, such as polyimides derived from poly(amic acid) salt precursors. Examples of polyalkylene oxides include C1-C 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 8 10 Alternatively, the hydrophilic polymer can be a hydrophobic polymer modified to have hydrophilic functional groups (e.g., hydroxy, amino, aldehyde, carboxy, thio, phosphato, etc.). Such hydrophobic polymers include polyolefins (polyethylene, polypropylene), polystyrene, polycarbonate, fluoropolymers (e.g., polyvinylidene fluoride, polytetrafluoroethylene), and polyetheretherketone (PEEK).
[0034]
[0036] The pendant cationic functional group is fixed (e.g., covalently bonded) to the substrate (or to a coating crosslinked thereon) and comprises any suitable cationic group, such as ammonium, sulfonium, phosphonium, or combinations thereof. In some embodiments, the cationic functional group is a quaternary ammonium group in which the nitrogen is attached to the substrate and three other moieties. Generally, a quaternary ammonium group has the structure -NR3 + Each instance of R is the same or different and is hydrogen, C 1~10 Alkyl, C 3~8 It is cycloalkyl or aryl. Preferably, the quaternary ammonium group is trialkylammonium.
[0035]
[0037] The counter anion of the cationic functional group is not limited since the counter anion is mobile and does not affect the permeability of the sample being treated. For example, the counter anion can be a hydride, a halide (e.g., F - , Cl - , Br - , or I - ), azide, carbonate, bicarbonate, chlorate, hypochlorite, perchlorate, hydroxide, cyanide, phosphate, sulfate, sulfite, sulfonate, thiosulfate, acetate, formate, oxalate, or combinations thereof. In a preferred embodiment, the counter anion is a halide.
[0036]
[0038] In some embodiments, the immobilized cationic functional groups can include primary amino groups, secondary amino groups, or a combination thereof, which can be formed into cationic groups by use of a chromatographic device. These groups can be the only pendant functional groups or can be in addition to the pendant cationic functional groups.
[0037]
[0039] The pendant cationic functional group is directly or indirectly attached to the substrate. Directly attached means that a bond exists between the substrate (or a coating crosslinked thereon) and the pendant cationic functional group. Indirectly attached means that a spacer exists between the substrate (or a coating crosslinked thereon) and the pendant cationic functional group. The spacer can be of any suitable length or structure (e.g., linear or branched) and will generally include one or more alkylene (-CH2-) groups, optionally one or more functional groups selected from hydroxy, alkoxy, amino, alkylamino, amide, ester, urea, urethane, and combinations thereof. The spacer group can be of any suitable length. For example, the spacer group can be a group having 1 to 10 (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10) atoms (e.g., carbon atoms). In one embodiment, the spacer group can be about 2 to 6 (ie, 1, 2, 3, 4, 5, or 6) atoms in length, preferably 3 carbon atoms in length.
[0038]
[0040] In some embodiments, at least one of the monomers includes a cationic functional group, such that when the substrate (or the coating crosslinked thereon) is polymerized and formed, the substrate already includes the cationic functional group. In other embodiments, the substrate (or the coating crosslinked thereon) is modified after its initial synthesis to add one or more cationic functional groups that are either directly or indirectly attached, as described herein. In one example, the substrate includes pendant amino groups that are quaternized to form pendant ammonium groups.
[0039]
[0041] The AEX layer can have any suitable pore structure, such as pore size (e.g., as evidenced by bubble point or, e.g., by KL as described in U.S. Pat. No. 4,340,479, or as evidenced by capillary condensation flow porometry), mean flow pore (MFP) size (e.g., when characterized using a porometer, e.g., a Porvair Porometer (Porvair, Norfolk, UK) or a porometer available under the trade name POROLUX (Porometer.com; Belgium)), pore rating, pore diameter (e.g., when characterized using, e.g., a modified OSU F2 test as described in U.S. Pat. No. 4,925,572), or removal rating media. The pore structure used depends on the size of the particles utilized, the composition of the fluid being treated, and the desired bleed level of the liquid being treated.
[0040]
[0042] For example, the AEX layer can have an average pore diameter of, for example, about 0.01 μm to about 10 μm. For example, the average pore size is 0.01 μm or greater (e.g., 0.01 μm or greater, 0.02 μm or greater, 0.05 μm or greater, 0.1 μm or greater, 0.2 μm or greater, 0.3 μm or greater, 0.5 μm or greater, 0.8 μm or greater, 1 μm or greater, 2 μm or greater, or 5 μm or greater). Alternatively or in combination, the average pore size is 10 μm or smaller (e.g., 8 μm or smaller, 5 μm or smaller, 2 μm or smaller, 1 μm or smaller, 0.8 μm or smaller, 0.5 μm or smaller, 0.3 μm or smaller, 0.2 μm or smaller, 0.1 μm or smaller, 0.08 μm or smaller, 0.05 μm or smaller, or 0.02 μm or smaller). Any two of the foregoing endpoints may be used to define a closed range, or one endpoint may be used to define an open-ended range. In some embodiments, the average pore size is about 0.1 μm to about 5 μm, about 0.1 μm to about 2 μm, 0.2 μm to about 5 μm, 0.2 μm to about 1 μm, about 0.1 μm to about 0.2 μm, about 0.5 μm to about 2 μm, about 0.05 μm to about 0.3 μm, 0.1 μm, 2 μm, or 0.45 μm.
[0041]
[0043] The AEX layer can have any suitable thickness, such as from about 50 μm to about 300 μm. For example, the average thickness can be 50 μm or greater (e.g., 60 μm or greater, 70 μm or greater, 80 μm or greater, 100 μm or greater, 120 μm or greater, 140 μm or greater, 160 μm or greater, 180 μm or greater, 200 μm or greater, 220 μm or greater, 240 μm or greater, 260 μm or greater, or 280 μm or greater). Alternatively or in combination, the average thickness is 300 μm or less (e.g., 280 μm or less, 260 μm or less, 240 μm or less, 220 μm or less, 200 μm or less, 180 μm or less, 160 μm or less, 140 μm or less, 120 μm or less, 100 μm or less, 80 μm or less, 70 μm or less, or 60 μm or less). Any two of the foregoing endpoints may be used to define a closed range, or one endpoint may be used to define an open-ended range. In some embodiments, the average pore size is about 60 μm to about 200 μm, about 80 μm to about 170 μm, 90 μm to about 160 μm, 100 μm to about 200 μm, or about 100 μm to about 200 μm.
[0042] Hydrophobic interaction layer
[0044] In general, a hydrophobic interaction (HIC) layer is any semipermeable membrane that includes a substrate that includes immobilized alkyl and / or phenyl-containing groups. The substrate can be any suitable material, such as polyethersulfone (PES), cellulose, methacrylate, hydrophilic polymers, or any combination thereof.
[0043]
[0045] In some embodiments, the substrate of the HIC layer comprises a polyethersulfone substrate that may or may not include a crosslinked coating. The crosslinked coating may be the same as described for the AEX layer, where one or more monomers include alkyl and / or phenyl-containing groups, or the crosslinked coating is later modified to include alkyl and / or phenyl-containing groups.
[0044]
[0046] In some embodiments, the substrate of the HIC layer comprises cellulose. Suitable cellulose polymers include cellulose, regenerated cellulose, cellulose esters (e.g., cellulose acetate, cellulose propionate, cellulose butyrate, cellulose acetate butyrate), hydrolyzed cellulose esters, cellulose nitrate (also known as nitrocellulose), methylcellulose, ethylcellulose, and combinations thereof (e.g., a mixture of cellulose acetate and cellulose nitrate).
[0045]
[0047] In a preferred aspect of the invention, the HIC layer comprises hydrolyzed cellulose acetate containing fixed alkyl and / or phenyl-containing groups, preferably phenyl groups. In some embodiments of this aspect, the cellulose acetate is reinforced, e.g., with fibers comprising cellulose (e.g., regenerated cellulose).
[0046]
[0048] In one example, the substrate comprises a cellulose ester (e.g., cellulose acetate) that is contacted with a solution that swells the cellulose ester substrate and / or hydrolyzes the ester groups to hydroxyl groups to form a cellulose hydrate (hydrolyzed cellulose acetate) substrate. The solution comprises water, one or more organic solvents, such as an alcohol (e.g., ethanol), or a combination thereof. To simultaneously swell and hydrolyze the cellulose ester, the solution requires water, and optionally an organic solvent. Otherwise, the swelling and hydrolysis can be carried out in stages. The solution can further comprise one or more additives, such as an acid (e.g., acetic acid), a salt of an acid (e.g., Group 1 or 2 salts, such as chlorides, sulfates, nitrates, phosphates, acetates, formates, etc., such as sodium chloride, sodium sulfate, sodium acetate, etc.), and combinations thereof. If desired, the cellulose hydrate substrate can be crosslinked with one or more crosslinking agents, solvents, and / or catalysts, as described herein.
[0047]
[0049] In some embodiments, the substrate of the HIC layer comprises a methacrylate polymer. Examples of methacrylate polymers include polymethyl methacrylate and methyl methacrylate copolymers.
[0048]
[0050] In some embodiments, the substrate of the HIC layer comprises a hydrophilic polymer. Examples of suitable hydrophilic polymers include polyamides, polyimides, polyalkylene oxides, hydrophilic polyurethanes, polyvinylpyrrolidones, polyacrylamides, polyacrylic acids, and polyvinyl alcohols. Examples of polyamides include nylons, such as nylon 4,6, nylon 6, nylon 6,6, nylon 11, and / or nylon 12. Examples of polyimides include aliphatic polyimides, aromatic polyimides, or mixtures thereof, such as polyimides derived from poly(amic acid) salt precursors. Examples of polyalkylene oxides include C1-C 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 8 10 Polyalkylene oxides are available.
[0049]
[0051] The pendant alkyl and / or phenyl-containing groups are anchored (eg, covalently bonded) to the substrate (or to a crosslinked coating thereon).
[0050]
[0052] Generally, the alkyl portion of the alkyl-containing group is a straight or branched C 1~10 Alkyl (e.g., C1, C2, C3, C4, C5, C6, C7, C8, C9 or C 10 Examples of alkyl groups include methyl, ethyl, n-propyl, n-butyl, s-butyl, i-butyl, t-butyl, n-pentyl, i-pentyl, neo-pentyl, t-pentyl, hexyl, heptyl, octyl, nonyl, and decyl. The alkyl-containing group may be unsubstituted or may be C 3~8 Cycloalkyl (C3, C4, C5, C6, C7 or C8 cycloalkyl), halo (e.g., F, Br, Cl and / or I), halo-C1-C 10 Alkyl, Nitro, C 2~6 It may be substituted with one or more (e.g., 1, 2, 3, 4, 5, or 6) substituents, such as alkenyl, aryl (e.g., phenyl, naphthyl), and combinations thereof. The substituents may be the same or different, but are preferably the same. In some embodiments, the alkyl-containing group is n-butyl, hexyl, or octyl.
[0051]
[0053] Generally, the phenyl portion of the phenyl-containing group is unsubstituted or 1~10 Alkyl (e.g., C1, C2, C3, C4, C5, C6, C7, C8, C9 or C 10 Alkyl), C 3~8 Cycloalkyl (C3, C4, C5, C6, C7 or C8 cycloalkyl), halo (e.g., F, Br, Cl and / or I), nitro, C 2~6It is substituted with one or more (e.g., 1, 2, 3, 4, 5, or 6) substituents, such as alkenyl, aryl (e.g., phenyl, naphthyl), and combinations thereof. The substituents can be the same or different, but are preferably the same. When phenyl is substituted with a substituent, an aromatic ring hydrogen is replaced with the substituent, which can occur at any available hydrogen, e.g., at the 2-, 3-, 4-, 5-, and / or 6-position, with the 1-position being the point of attachment, directly or indirectly, of the phenyl group to the substrate. In some embodiments, the phenyl-containing group is phenyl.
[0052]
[0054] In any of the above embodiments, a range of numbers of atoms in the structure is given (e.g., C 1~10 , C 1~8 , C 1~6 , C 1~4 , etc.), it is specifically contemplated that any subrange or individual number of carbon atoms included in the stated range may also be used. Thus, for example, a description of a range of 1 to 8 carbon atoms (e.g., C1-C8), 1 to 6 carbon atoms (e.g., C1-C6), 1 to 4 carbon atoms (e.g., C1-C4), 1 to 3 carbon atoms (e.g., C1-C3), or 2 to 8 carbon atoms (e.g., C2-C8) used with respect to any chemical group referenced herein (e.g., alkyl, cycloalkyl, etc.) is intended to include a range of 1, 2, 3, 4, 5, 6, 7, and / or 8 carbon atoms, as well as any subrange or individual number of carbon atoms included in the stated range, as appropriate. As needed, for example, 1-2 carbon atoms, 1-3 carbon atoms, 1-4 carbon atoms, 1-5 carbon atoms, 1-6 carbon atoms, 1-7 carbon atoms, 1-8 carbon atoms, 2-3 carbon atoms, 2-4 carbon atoms, 2-5 carbon atoms, 2-6 carbon atoms, 2-7 carbon atoms, 2-8 carbon atoms, 3-4 carbon atoms, 3-5 carbon atoms, 3-6 carbon atoms, 3-7 carbon atoms, 3-8 carbon atoms, 4-5 carbon atoms, 4-6 carbon atoms, 4-7 carbon atoms, 4-8 carbon atoms, etc.) are included and specifically described.
[0053]
[0055] The pendant alkyl and / or phenyl-containing groups are directly or indirectly attached to the substrate (or coating crosslinked thereon). Directly attached means that a bond exists between the substrate (or coating crosslinked thereon) and the pendant alkyl and / or phenyl-containing groups. Indirectly attached means that a spacer exists between the substrate (or coating crosslinked thereon) and the pendant alkyl and / or phenyl-containing groups. The spacer can be of any suitable length or structure (e.g., linear or branched) and will generally include one or more alkylene (-CH2-) groups, optionally one or more functional groups such as hydroxy, halo, alkoxy, amino, alkylamino, amide, ester, urea, urethane, and combinations thereof. The spacer group can be of any suitable length. For example, the spacer group can be a group having 1 to 10 (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10) atoms (e.g., carbon atoms). In one embodiment, the spacer group can be about 2 to 6 (ie, 1, 2, 3, 4, 5, or 6) atoms in length, preferably 3 carbon atoms in length.
[0054]
[0056] In some embodiments, at least one of the monomers comprises an alkyl and / or phenyl-containing group, such that when the substrate (or the coating crosslinked thereon) is polymerized and formed, the substrate (or the coating crosslinked thereon) already comprises the alkyl and / or phenyl-containing group. In other embodiments, the substrate (or the coating crosslinked thereon) is modified after its initial synthesis to add one or more alkyl and / or phenyl-containing groups, either directly or indirectly attached, as described herein. In one example, the substrate comprises one or more functional groups, such as hydroxyl, epoxide and / or aldehyde groups, and may be modified using, for example, alkyl glycidyl ethers, alkyl amines (e.g., butylamine, hexylamine, octylamine), phenyl glycidyl ether, or aniline to add alkyl and / or phenyl-containing groups.
[0055]
[0057] The HIC layer can have any suitable pore structure, such as pore size (e.g., as evidenced by bubble point or, e.g., by KL as described in U.S. Pat. No. 4,340,479, or as evidenced by capillary condensation flow porometry), mean flow pore (MFP) size (e.g., when characterized using a porometer, e.g., a Paul Baer porometer (Porvair, Norfolk, UK) or a porometer available under the trademark Porolax (Porometer.com; Belgium)), pore rating, pore diameter (e.g., when characterized using a modified OSU F2 test as described in U.S. Pat. No. 4,925,572), or removal rating media. The pore structure used depends on the size of the particles utilized, the composition of the fluid being treated, and the desired bleed level of the liquid being treated.
[0056]
[0058] For example, the HIC layer can have an average pore diameter of, for example, about 0.1 μm to about 20 μm, e.g., the average pore size is 0.1 μm or greater (e.g., 0.2 μm or greater, 0.3 μm or greater, 0.5 μm or greater, 0.8 μm or greater, 1 μm or greater, 2 μm or greater, 3 μm or greater, 5 μm or greater, 8 μm or greater, 10 μm or greater, 12 μm or greater, 15 μm or greater, or 18 μm or greater). Alternatively or in combination, the average pore size is 20 μm or smaller (e.g., 18 μm or smaller, 15 μm or smaller, 12 μm or smaller, 10 μm or smaller, 8 μm or smaller, 5 μm or smaller, 3 μm or smaller, 2 μm or smaller, 1 μm or smaller, 0.8 μm or smaller, 0.5 μm or smaller, 0.3 μm or smaller, or 0.2 μm or smaller). Any two of the foregoing endpoints may be used to define a closed range, or one endpoint may be used to define an open-ended range. In some embodiments, the average pore size is from about 0.1 μm to about 15 μm, from about 0.1 μm to about 10 μm, from 0.2 μm to about 5 μm, from 0.2 μm to about 1 μm, from about 1 μm to about 5 μm, from about 2 μm to about 4 μm, 3 μm, or 0.45 μm.
[0057]
[0059] The HIC layer can have any suitable thickness, such as from about 50 μm to about 400 μm. For example, the average thickness can be 50 μm or greater (e.g., 60 μm or greater, 70 μm or greater, 80 μm or greater, 100 μm or greater, 120 μm or greater, 140 μm or greater, 160 μm or greater, 180 μm or greater, 200 μm or greater, 220 μm or greater, 240 μm or greater, 260 μm or greater, 280 μm or greater, 300 μm or greater, 320 μm or greater, 340 μm or greater, 360 μm or greater, or 380 μm or greater). Alternatively or in combination, the average thickness is 400 μm or less (e.g., 380 μm or less, 360 μm or less, 340 μm or less, 320 μm or less, 300 μm or less, 280 μm or less, 260 μm or less, 240 μm or less, 220 μm or less, 200 μm or less, 180 μm or less, 160 μm or less, 140 μm or less, 120 μm or less, 100 μm or less, 80 μm or less, 70 μm or less, or 60 μm or less). Any two of the foregoing endpoints can be used to define a closed range, or one endpoint can be used to define an open-ended range. In some embodiments, the average pore size is from about 60 μm to about 300 μm, from about 80 μm to about 270 μm, from 90 μm to about 260 μm, from 100 μm to about 250 μm, or about 250 μm.
[0058] Both AEX and HIC layers
[0060] AEX and HIC membranes can be prepared by any suitable method, such as commercially purchased or synthesized using methods known to those skilled in the art. For example, commercially available AEX membranes include MUSTANG™ Q series (Pall, Port Washington, NY) and SARTOBIND Q™ or SARTOBIND STIC™ (Satorius AG, Goettingen, Germany). Commercially available HIC membranes include SARTOBIND™ Phenyl (Sartorius AG, Goettingen, Germany).
[0059]
[0061] The hydrophilicity and hydrophobicity of the polymer forming the substrate or layer can be measured by any suitable method, as required. For example, a small amount of water can be placed on a film or pressed pellet of the polymer, and the contact angle of the side view of the water drop (i.e., the angle of the liquid in contact with the solid surface) can be measured, for example, using a contact angle goniometer. Droplet measurement is the most common method of measuring contact angles. In general, contact angles less than 90° are considered hydrophilic materials, and contact angles greater than 90° are considered hydrophobic materials.
[0060]
[0062] Alternatively, the layer can have any desired critical wetting surface tension (CWST, e.g., as defined in U.S. Pat. No. 4,925,572). The porous membrane can have any desired critical wetting surface tension (CWST, e.g., as defined in U.S. Pat. No. 4,925,572). The CWST can be selected, for example, as known in the art and as further disclosed in, for example, U.S. Pat. Nos. 5,152,905, 5,443,743, 5,472,621 and 6,074,869.
[0061] Chromatography Devices
[0063] In a preferred embodiment, the chromatography device 100, 200 comprises a porous filter 150 (planar configuration), 250 (radial configuration) comprising an upstream first porous filter membrane 151, 251 comprising at least one AEX layer comprising a polyethersulfone substrate with a cross-linked coating comprising pendant quaternary ammonium groups, and a downstream second porous filter membrane 152, 252 comprising at least one HIC layer comprising cross-linked cellulose hydrate comprising pendant phenyl groups.
[0062]
[0064] Chromatography devices according to embodiments of the invention can have any number of AEX layers and any number of HIC layers. Generally, the device has at least two AEX layers and two HIC layers; in some embodiments, for example, 3, 4, 5, 6, 7, 8, 9, or more AEX layers, and 3, 4, 5, 6, 7, 8, 9, or more HIC layers. Chromatography devices according to embodiments of the invention can also have a different number of AEX layers compared to the HIC layers, for example, more AEX layers than HIC layers, or vice versa.
[0063]
[0065] The chromatography device may include additional elements, layers or components and may have different structures and / or functions, such as at least one of any one or more of: prefiltration, support, drainage, spacing and buffering. Illustratively, a filter may also include at least one additional element, such as a mesh and / or a screen. In a preferred embodiment, the device includes a downstream support element 160, 260.
[0064]
[0066] According to aspects of the invention, filters and filter elements can have a variety of configurations, including planar (e.g., as shown in FIG. 1), pleated, and hollow cylindrical (e.g., as shown in FIGS. 2A, 2B, and 2I).
[0065]
[0067] The chromatography device may be sterilizable. Any filter housing of suitable shape and providing at least one inlet and at least one outlet may be utilized. The filter housing may be manufactured from any suitable rigid impermeable material, including any impermeable thermoplastic material that is compatible with the fluid to be processed. In a preferred embodiment, the housing is manufactured from a polymer such as acrylic, polypropylene, polystyrene or polycarbonate resin.
[0066] Purification method
[0068] In one aspect, a method of purification includes: (a) passing a fluid containing nucleic acid through a chromatography device comprising: a filter housing having an inlet and an outlet, the filter housing defining a fluid flow path between the inlet and the outlet; and a porous filter disposed in the filter housing across the fluid flow path, the porous filter comprising a first porous filter element; and a second porous filter element in contact with the first porous filter element, the first porous filter element comprising at least one anion exchange (AEX) layer and the second porous filter element comprising at least one hydrophobic interaction (HIC) layer; (b) binding the nucleic acid to the AEX layer; (c) eluting the nucleic acid from the AEX layer into a high salt buffer; (d) binding the nucleic acid to the HIC layer; and (e) eluting the nucleic acid from the HIC layer into a low salt buffer.
[0067]
[0069] For example, nucleic acids are captured in the AEX layer under binding conditions (pH above the isoelectric point and conductivity below that required for binding). The membrane is washed with a binding buffer, eluted from the AEX layer with a salt solution (such as sodium citrate or ammonium sulfate), and bound onto the HIC layer. The HIC membrane is washed with a salt buffer and eluted with an AEX binding buffer (HIC elution buffer).
[0068]
[0070] To purify enveloped viruses such as lentiviruses, the biomolecule of interest is dissolved in a buffer with a pH higher than its isoelectric point (hence negatively charged) and a conductivity lower than that required for elution from the AEX layer, and passed through the chromatography device at a flow rate of 10 membrane volumes / min, such that the biomolecule binds to the AEX layer. A wash with binding buffer is performed to elute the biomolecule (causing desorption by equilibration - elution buffer), and the biomolecule is eluted from the AEX layer using a buffer with a conductivity high enough to bind the biomolecule to the HIC layer. The HIC layer with bound biomolecule is washed with elution buffer and eluted with a buffer with a pH higher than the isoelectric point of the biomolecule and a low conductivity.
[0069]
[0071] For example, alternative buffers such as MES, HEPES, MOPS, TAPSO, BES, PIPES, ACES may be used. Sodium chloride, magnesium chloride at a minimum concentration of 1.5M may be used instead of sodium citrate or ammonium sulfate.
[0070]
[0072] The following examples further illustrate the invention but, of course, should not be construed as in any way limiting its scope.
[0071] Example 1
[0073] This example demonstrates lentivirus purification using a chromatography device according to one embodiment of the present invention.
[0072]
[0074] A chromatography device is provided generally as shown in Figure 1C. The chromatography device includes 4 layers of AEX membranes and 4 layers of HIC membranes with a minimum diameter of 0.1 cm assembled in a filter holder with the AEX membranes on the inlet (upstream) side and the HIC membranes on the outlet (downstream) side, washed with 10 mL of 1 M NaOH solution, and then equilibrated with 25 mL of 25 mM Tris pH 8, 100 mM NaCl (prepared from 25 mL of 1 M Tris and 25 mL of 5 M NaCl added to 950 mL of DI water).
[0073]
[0075] Conductivity of about 15 mS / cm is approximately 1.6 x 10 6 10 mL of clarified lentivirus harvested from HEK293 cells containing 50 vectors / mL is passed through the chromatography device at flow rates ranging from 1 to 10 membrane volumes / min. The membrane is washed with 4 mL of AEX equilibration buffer (25 mM Tris pH 8 100 mM NaCl) and eluted from the AEX medium / bound to the HIC medium with 4 mL of 1.5 M sodium citrate pH 8.0 (prepared by adding 441.15 g of sodium citrate dihydrate and 25 mL of 1 M Tris pH 8 in a total of 1 L of DI water). The device is washed with 4 mL of elution buffer. The HIC membrane is purified to yield approximately 8.3 x 10 IgG free of DNA and host cell proteins. 5 Elute with 4 mL of AEX equilibration buffer (25 mM Tris, pH 8, 100 mM NaCl) (low salt buffer) to contain 1 vector / mL (15% yield as measured by functional titer assay after 2 freeze-thaw cycles). The conductivity of the eluted lentiviral harvest is approximately 40 mS / cm.
[0074]
[0076] Lentiviruses are harvested with high purity, free of host cell proteins and DNA, and do not require buffer dilution.
[0075] Example 2
[0077] This example demonstrates lentivirus purification using a chromatography device according to one embodiment of the invention and, in contrast to Example 1, the yield is measured without freeze-thawing.
[0076]
[0078] The procedure summarized in Example 1 was generally followed, except that yields were measured using a Gyrolab® p24 kit for lentiviral titer determination (2021; Gyros Protein Technologies) according to the manufacturer's instructions.
[0077]
[0079] Yields (using an ELISA assay measuring free surface p24 protein) are greater than 30%.
[0078] Example 3
[0080] This example describes a chromatography device according to another embodiment of the invention.
[0079]
[0081] A chromatography device is provided, generally as shown in Figures 2B and 2I. The chromatography device includes an 8-layer AEX pleated membrane and an 8-layer pleated HIC membrane, where the AEX membrane is wrapped around the HIC membrane and assembled into a housing with the AEX membrane on the inlet (upstream) side.
[0080]
[0082] In one embodiment, the eluted lentivirus, which is free of DNA and host cell proteins and does not require dilution with buffer, is analyzed by transducing unit (TU) assay using fluorescence activated cell sorting (FACS) after freeze-thawing to determine lentiviral recovery (vectors / mL).
[0081]
[0083] All references cited in this specification, including publications, patent applications, and patents, are herein incorporated by reference to the same extent as if each reference was individually and specifically indicated to be incorporated by reference and was set forth in its entirety herein.
[0082]
[0084] Unless otherwise indicated herein or clearly contradicted by context, in the context of describing the invention (particularly in the context of the claims below), use of the terms "a" and "an" and "the" and "at least one" and similar referents are to be construed to cover both the singular and the plural. Unless otherwise indicated herein or clearly contradicted by context, use of the term "at least one" (e.g., "at least one of A and B") following a list of one or more items is to be construed to mean one item selected from the listed item (A or B) or any combination of two or more of the listed items (A and B). The terms "comprising," "having," "including," and "containing" are to be construed as open-ended terms (i.e., meaning "including but not limited to") unless otherwise indicated. Descriptions of ranges of values herein are merely intended to be used as a shorthand method of individually referring to each separate value within the range, and each separate value is incorporated herein as if it were individually recited herein, unless otherwise indicated herein. All methods described herein may be performed in any suitable order, unless otherwise indicated herein or clearly contradicted by context. The use of any examples or exemplary language provided herein (e.g., "etc.") is intended merely to better clarify the invention, and does not pose a limitation on the scope of the invention unless specifically claimed. No language in this specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
[0083]
[0085] Preferred embodiments of the present invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred embodiments may become apparent to those skilled in the art upon reading the foregoing description. The inventors anticipate that skilled artisans will utilize such variations as appropriate, and the inventors intend the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
Claims
1. A chromatography device for purifying an enveloped virus, comprising: (a) a filter housing having an inlet and an outlet and defining a fluid flow path between the inlet and the outlet; (b) a chromatography device comprising a porous filter disposed in the filter housing across the fluid flow path, the porous filter comprising: (i) a first porous filter element; and (ii) a second porous filter element in contact with the first filter element, the second porous filter element being disposed downstream of the first filter element, the first filter element comprising at least one anion exchange (AEX) membrane and the second filter element comprising at least one hydrophobic interaction (HIC) membrane. Chromatography devices.
2. The chromatography device described in claim 1, wherein the enveloped virus is a lentivirus.
3. The chromatography device of claim 1 , wherein the AEX membrane and the HIC membrane are planar membranes.
4. 2. The chromatography device of claim 1, wherein the porous filter comprises a hollow cylindrical filter and the AEX membrane surrounds the HIC membrane.
5. The chromatography device of any one of claims 1 to 4, wherein the porous filter comprises two or more AEX membranes and two or more HIC membranes.
6. A method for purifying an enveloped virus comprising: (a) passing a fluid containing an enveloped virus through a chromatography device comprising: a filter housing having an inlet and an outlet, the filter housing defining a fluid flow path between the inlet and the outlet; and a porous filter disposed in the filter housing across the fluid flow path, the porous filter comprising a first porous filter element; and a second porous filter element in contact with the first filter element, the second porous filter element being disposed downstream of the first porous filter element, the first filter element comprising at least one anion exchange (AEX) membrane and the second filter element comprising at least one hydrophobic interaction (HIC) membrane; (b) binding the enveloped virus to the at least one AEX membrane; (c) eluting the enveloped virus from the at least one AEX membrane into high salt; (d) binding the enveloped virus to the at least one HIC membrane; (e) eluting the enveloped virus from the at least one HIC membrane into a low salt buffer.
7. The method described in claim 6, wherein the enveloped virus is a lentivirus.
Citation Information
Patent Citations
Method and device for isolating and purifying a polynucleotide of interest on a manufacturing scale
EP1321176A1
Purification of biomolecules
JP2015522019A
Mixed bed ion exchange adsorbent
JP2018501222A
Molecule separation device and method combining multiple filtration media
US20010025818A1
